spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Arrow 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 14 Jun 2024
TALVEY(R) (talquetamab-tgvs) Demonstrates Highly Durable, Longer-Term Responses in Patients with Relapsed or Refractory Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jun 2024
Zeto obtains FDA 510(k) clearance for its groundbreaking next-generation EEG brain monitoring product, ONE.
Devices Neurology Monitoring FDA
 HSMN NewsFeed - 1 Mar 2024
Boston Scientific Receives FDA Approval for the AGENT(TM) Drug-Coated Balloon
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 15 Feb 2024
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 18 Jan 2024
Cepheid Receives Expanded FDA Clearance with CLIA Waiver for Xpert(R) Xpress MVP
Diagnostics FDA
 HSMN NewsFeed - 20 Nov 2023
FDA Grants Orphan Drug Designation to NeoImmuneTech's NT-I7 for the Treatment of Acute Radiation Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Nov 2023
Ad Astra Diagnostics receives 510(k) clearance of QScout(TM) hematology analyzer, the first to report measures of infection and severity at point-of-care
Diagnostics FDA
 HSMN NewsFeed - 3 Nov 2023
Actinium Appoints Lynn Bodarky as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Oct 2023
Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest
Devices Cardiology FDA
 HSMN NewsFeed - 9 May 2023
Omeq Medical Receives FDA Regulatory Clearance for its Smart Device for Epidural Injections
Devices FDA
 HSMN NewsFeed - 27 Mar 2023
BrainStorm Cell Therapeutics Announces FDA Advisory Committee Meeting to Review Biologics License Application for NurOwn(R) for the Treatment of ALS
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 17 Feb 2023
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
Devices Cardiology Regulatory
 HSMN NewsFeed - 27 Dec 2022
BrainStorm Cell Therapeutics Announces Type A Meeting with FDA Granted for NurOwn(R)
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 9 Dec 2022
Janssen Submits Biologics License Application to U.S. FDA for Talquetamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Dec 2022
Dantari Debuts with $47 Million Series A to Advance Best-in-Class Targeted Medicines for Solid Tumors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 10 Nov 2022
BrainStorm Cell Therapeutics Receives Refusal to File Letter from FDA for its New Biologics License Application for NurOwn for the treatment of ALS
Biopharmaceuticals Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 31 Oct 2022
Actinium Announces Positive Top-line Results from Pivotal Phase 3 SIERRA Trial of Iomab-B in Patients with Active Relapsed or Refractory Acute Myeloid Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Oct 2022
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Sep 2022
Harrow Announces U.S. FDA Approval of IHEEZO(TM) (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 15 Sep 2022
BrainStorm Cell Therapeutics Announces Peer Reviewed Publication of Results from the NurOwn(R) Phase 2 Progressive MS Trial in Multiple Sclerosis Journal
Regenerative Medicine Neurology
 HSMN NewsFeed - 26 Aug 2022
Inhibikase Therapeutics Announces FDA Clearance of Investigational New Drug Application for IkT-001Pro for the Treatment of Chronic Myelogenous Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Jul 2022
Study shows that selection of breast cancer patients for adjuvant bisphosphonate therapy based on Inbiomotion's MAFTEST(R) reduces the risk of death in comparison with current clinical guidance
Diagnostics Oncology
 HSMN NewsFeed - 9 Jun 2022
Scopio Labs Awarded FDA Clearance for High Throughput Hematology Digital Cell Morphology Platform, Replacing Microscopes with Digitization
Devices Diagnostics FDA
 HSMN NewsFeed - 23 May 2022
MindMed Appoints Schond L. Greenway as Chief Financial Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 13 May 2022
Medtronic receives FDA approval for latest generation drug-eluting coronary stent system
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 5 Apr 2022
MindMed Appoints Francois Lilienthal, MD as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Mar 2022
Stem cell biotech Neuroplast enrolls first patient in Phase II clinical trial of transformative Neuro-Cells(R) treatment for Traumatic Spinal Cord Injury
Regenerative Medicine Neurology
 HSMN NewsFeed - 24 Mar 2022
HLT, Inc. Gains FDA Approval for Two TAVR Clinical Studies
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 7 Mar 2022
Elixirgen Therapeutics Partners with Taisho Pharmaceutical on Therapeutics for Aging-Associated Diseases
Biopharmaceuticals
 HSMN NewsFeed - 23 Feb 2022
Abilita Bio Appoints Dan Bradbury to its Newly Formed Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Feb 2022
Vertos Medical Announces Results Showing Meaningful Mobility Improvement Following mild(R) Procedure
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 21 Jan 2022
Medtronic Foundation launches new STEM partnerships to serve over 60,000 underserved and underrepresented students
Devices
 HSMN NewsFeed - 19 Jan 2022
Amber Implants Closes US$10 M Series A Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 11 Jan 2022
New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities
Devices Interventional
 HSMN NewsFeed - 29 Dec 2021
MindMed Announces Transitions to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Dec 2021
FDA Authorizes Further NurOwn(R) Dosing Under Expanded Access Program
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 15 Dec 2021
FDA Approves First Drug to Prevent Graft Versus Host Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Dec 2021
MindMed Appoints Robert Barrow as Chief Executive Officer and Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2021
FDA Grants Profounda Orphan Drug Designation Approval for Treatment of Invasive Candidiasis with Miltefosine
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Sep 2021
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Sep 2021
B dot Medical Successfully Develops Compact Scanning Magnet for Proton Cancer Therapy System
Devices Oncology Radiology
 HSMN NewsFeed - 2 Aug 2021
Abbott's FreeStyle(R) Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management
Devices Monitoring Endocrinology FDA
 HSMN NewsFeed - 26 Jul 2021
Medtronic Launches Newest-Generation Drug Coated Balloon Catheter in Europe for Treatment of Coronary Artery Disease
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 20 Jul 2021
First Light Diagnostics Receives FDA Clearance for its Rapid Clostridiodes difficile Test on the MultiPath(R) Analyzer
Diagnostics FDA
 HSMN NewsFeed - 12 Jul 2021
Janssen Announces U.S. FDA Approval of DARZALEX FASPRO(R) (daratumumab and hyaluronidase-fihj) in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Jun 2021
Jim Vasselli, M.D., Joins Aulos Bioscience as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Jun 2021
MindMed Announces Chief Executive Officer Transition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2021
Ortho Regenerative Technologies Receives Clinical Hold Letter From the U.S. FDA
Regenerative Medicine Orthopaedic FDA
 HSMN NewsFeed - 1 Jun 2021
Janssen Announces U.S. FDA Breakthrough Therapy Designation Granted for Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 May 2021
Abbott Receives CE Mark for Navitor(TM), the Latest-Generation Transcatheter Aortic Valve Implantation (TAVI) System to Treat Aortic Stenosis
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 12 Apr 2021
Grünenthal acquires Mestex AG and its Phase-III-ready investigational medicine MTX-071 for the treatment of pain associated with osteoarthritis of the knee
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 31 Mar 2021
CTI BioPharma Announces Completion of Rolling Submission of New Drug Application (NDA) for Pacritinib in Myelofibrosis Patients with Severe Thrombocytopenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Mar 2021
Abbott Introduces NeuroSphere(TM) Virtual Clinic, First-of-its-Kind Remote Neuromodulation Patient-Care Technology in the U.S.
Devices Neurology Product Launch
 HSMN NewsFeed - 12 Feb 2021
The Lancet Publishes Libtayo(R) (cemiplimab) Data Showing Extended Overall Survival in Patients with First-line Advanced Non-small Cell Lung Cancer with PD-L1 Expression of ≥50%
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Jan 2021
Ortho Regenerative Technologies Enters Into Global License With Hanuman Pelican, Inc.
Devices Orthopaedic Licensing
 HSMN NewsFeed - 21 Dec 2020
Astellas Reports XOSPATA(R) (gilteritinib) in Combination with Azacitidine Did Not Meet Endpoint of Overall Survival in Newly Diagnosed FLT3 Mutation-Positive Acute Myeloid Leukemia Patients Ineligible for Intensive Induction Chemotherapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Dec 2020
BrainStorm Announces NurOwn(R) Expanded Access Program
Regenerative Medicine Neurology Product Launch
 HSMN NewsFeed - 8 Dec 2020
Vertos Medical Announces ASC Reimbursement Increase for the mild(R) Procedure
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 2 Dec 2020
Abbott's FreeStyle Libre 2 Now Approved for Adults and Children with Diabetes in Canada, Featuring Unsurpassed 14-Day Accuracy and Optional Alarms
Devices Monitoring Endocrinology Regulatory
 HSMN NewsFeed - 1 Dec 2020
Actinium Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinical Development
Biopharmaceutical Personnel
 HSMN NewsFeed - 23 Nov 2020
Rapid Medical Expands Comaneci(TM) CE Mark Indication to Include Vasospasm Treatment
Devices Interventional Neurology Regulatory
 HSMN NewsFeed - 23 Nov 2020
FDA Clears First of its Kind Algorithm Suite for Personal ECG
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 23 Nov 2020
BrainStorm to present NurOwn(R) Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MND
Regenerative Medicine Neurology
 HSMN NewsFeed - 17 Nov 2020
BrainStorm Announces Topline Results from NurOwn(R) Phase 3 ALS Study
Regenerative Medicine Neurology
 HSMN NewsFeed - 4 Nov 2020
Sobi launch Doptelet(R) (avatrombopag) in Europe
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 3 Nov 2020
TheraCell Announces First Surgical Use Of TheraFuze DBF(R) Fiber Anchor(TM) For Pedicle Screw Augmentation
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 2 Nov 2020
Boston Scientific Receives FDA Approval for the Ranger(TM) Drug-Coated Balloon
Devices Interventional FDA Product Launch
 HSMN NewsFeed - 7 Oct 2020
Citius Pharmaceuticals Signs an Exclusive Worldwide Licensing Agreement with Novellus Therapeutics for Unique iMSC-Therapy for Acute Inflammatory Respiratory Conditions including COVID-19 Related Acute Respiratory Distress Syndrome (ARDS)
Biopharmaceuticals Regenerative Medicine Licensing
 HSMN NewsFeed - 28 Sep 2020
Boston Scientific Launches ACURATE neo2(TM) Aortic Valve System in Europe
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 8 Sep 2020
Menlo Therapeutics Announces Completion of Corporate Name Change to VYNE Therapeutics
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 8 Sep 2020
FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 7 Sep 2020
Ascentage Pharma's Bcl-2 Inhibitor APG-2575 Granted Orphan Drug Designation by the FDA for the Treatment of Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Sep 2020
Abbott's FreeStyle(R) Libre 2 iCGM System Now Available to Medicare Beneficiaries
Devices Monitoring Endocrinology Reimbursement
 HSMN NewsFeed - 21 Aug 2020
Cipla and Stempeutics collaborate for launch of Stempeucel(R), first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 6 Jul 2020
ANI Pharmaceuticals Announces Acquisition of Fluconazole Tablets
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 26 Jun 2020
Citius Receives FDA Response on Pre-Investigational New Drug (PIND) Application for its Induced Mesenchymal Stem Cells (iMSCs) to Treat Acute Respiratory Distress Syndrome (ARDS) in Patients with COVID-19
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Jun 2020
BrainStorm Expands Clinical Pipeline to Evaluate NurOwn(R) for the Treatment of Alzheimer's Disease
Regenerative Medicine Neurology
 HSMN NewsFeed - 15 Jun 2020
Abbott's FreeStyle(R) Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards
Devices Monitoring Endocrinology FDA
 HSMN NewsFeed - 8 Jun 2020
Neurelis Announces Rapid and Broad Payer Coverage of the Company's Flagship Product, VALTOCO(R) (Diazepam Nasal Spray)
Biopharmaceuticals Drug Delivery Reimbursement
 HSMN NewsFeed - 8 Jun 2020
Insmed Receives FDA Breakthrough Therapy Designation for Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE)
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Jun 2020
FDA Clears Innovative Angioplasty Scoring and Cutting Platform
Devices Interventional FDA
 HSMN NewsFeed - 1 Jun 2020
Olympus Announces Market Availability of the New TJF-Q190V Duodenoscope
Devices Product Launch
 HSMN NewsFeed - 27 May 2020
BrainStorm Appoints Pharmaceutical Veteran Stacy R. Lindborg, Ph.D. as Executive Vice President, Head of Global Clinical Research
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 19 May 2020
Invivoscribe Announces FDA Approval for Distribution of the LeukoStrat CDx FLT3 Mutation Assay as an IVD Kit in the United States
Diagnostics Oncology FDA
 HSMN NewsFeed - 18 May 2020
Edwards PASCAL Transcatheter Valve Repair System Receives European Approval For Tricuspid Repair
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 1 Apr 2020
Blueprint Medicines Announces the Achievement of Key Portfolio Milestones
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Mar 2020
AbbVie Receives European Commission Approval of VENCLYXTO(R) Combination Regimen for Patients with Previously-Untreated Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 9 Mar 2020
Menlo Therapeutics and Foamix Pharmaceuticals Complete Merger, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 21 Feb 2020
Ampio Provides Corporate Update
Biopharmaceuticals Orthopaedic
 HSMN NewsFeed - 19 Feb 2020
Abbott and Insulet Partner to Integrate Next-Generation Glucose Sensing and Automated Insulin Delivery Technologies for Seamless Diabetes Care
Devices Monitoring Drug Delivery Endocrinology
 HSMN NewsFeed - 31 Jan 2020
AbbVie Receives Positive CHMP Opinion for VENCLYXTO(R) as a Chemotherapy-Free Combination Regimen for Patients with Previously Untreated Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 29 Jan 2020
Monoferric(R) (Ferric Derisomaltose) Injection Is Approved by the US FDA for the Treatment of Iron Deficiency Anemia
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Jan 2020
Profusa Receives CE Mark Approval to Market the Wireless Lumee(R) Oxygen Platform for Continuous, Real-Time Monitoring of Tissue Oxygen
Devices Monitoring Regulatory
 HSMN NewsFeed - 9 Jan 2020
BioDirection(R), Inc. Appoints Dr. Jean-Luc Boulnois to its Board of Directors
Devices Neurology Personnel
 HSMN NewsFeed - 7 Jan 2020
IFM Therapeutics Appoints Michael Cooke, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jan 2020
Pulmatrix Announces Kinase Inhibitor Licensing Agreement with Lung Cancer Initiative at Johnson & Johnson
Biopharmaceuticals Oncology Drug Delivery Licensing
 HSMN NewsFeed - 19 Dec 2019
Michigan Community Hospital Begins Patient Treatments with ViewRay's MRIdian Linac
Devices Oncology
 HSMN NewsFeed - 17 Dec 2019
ArcherDX Announces Close of $55 Million Series C Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 10 Dec 2019
Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at the 2019 ASH Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Nov 2019
Janssen Announces Submission of Supplemental New Drug Application to U.S. FDA Seeking Approval of IMBRUVICA(R) (ibrutinib) in Combination with Rituximab for Previously Untreated Patients with Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Oct 2019
European Commission Approves Astellas' XOSPATA(TM) for Patients with Relapsed or Refractory Acute Myeloid Leukemia with Mutations Detected using Invivoscribe's LeukoStrat(R) CDx FLT3 Mutation Assay
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 25 Oct 2019
European Commission Approves Astellas' XOSPATA(TM) (gilteritinib) as a Monotherapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 18 Oct 2019
Nplate(R) (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Oct 2019
Upsher-Smith Laboratories Launches Tosymra(TM) (sumatriptan) Nasal Spray For The Acute Treatment Of Migraine In Adults
Biopharmaceuticals Neurology Drug Delivery Product Launch
 HSMN NewsFeed - 17 Sep 2019
Abbott Announces European Approval of Two Life-saving Heart Devices for Babies and Children
Devices Cardiology Regulatory
 HSMN NewsFeed - 13 Sep 2019
Abbott's Revolutionary FreeStyle(R) Libre System Now Reimbursed in the Two Largest Provinces in Canada
Devices Monitoring Endocrinology Reimbursement
 HSMN NewsFeed - 12 Sep 2019
Olympus Launches New Generation Video Rhino-Laryngoscopes
Devices Product Launch
 HSMN NewsFeed - 10 Sep 2019
Cologuard(R) Helps More People Get Screened In A Cost-Effective Way
Diagnostics Oncology
 HSMN NewsFeed - 12 Aug 2019
CASI Pharmaceuticals Announces Launch of EVOMELA(R) (melphalan for injection) in China
Biopharmaceuticals Oncology Product Launch
 HSMN NewsFeed - 6 Aug 2019
Vertos Medical Appoints New Vice President of Sales
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 26 Jul 2019
MiRus Receives FDA Clearance for Lowest Profile Anterior Cervical Plate System
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 22 Jul 2019
Zynex Expands Executive Team, Appoints Joseph Papandrea Chief Operating Officer
Devices Personnel
 HSMN NewsFeed - 22 Jul 2019
Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Jul 2019
NuVasive Launches Pulse(TM) - the First Integrated Technology Platform to Enable Better Spine Surgery
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 21 Jun 2019
Daiichi Sankyo Provides Update on FDA Review of Quizartinib for the Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Jun 2019
Oncologie Closes an $80M Series B Financing for Clinical-Stage Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 30 May 2019
U.S. FDA Approves Supplemental New Drug Application Adding Overall Survival Data for XOSPATA(R) (gilteritinib)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 May 2019
Mallinckrodt Files Suit against U.S. Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) to Protect Medicaid Patient Access to Acthar(R) Gel
Biopharmaceuticals Reimbursement Litigation
 HSMN NewsFeed - 20 May 2019
UCB announces NAYZILAM(R) (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 17 May 2019
U.S. FDA Approves GATTEX(R) (teduglutide) for Children 1 Year of Age and Older With Short Bowel Syndrome (SBS)
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 16 May 2019
Pulmatrix Announces Leadership Change
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 9 May 2019
Boston Scientific Announces Agreement To Acquire Vertiflex, Inc.
Devices Orthopaedic Neurosurgery Mergers & Acquisitions
 HSMN NewsFeed - 2 May 2019
Concept Medical Inc. Granted 'Breakthrough Device Designation' From FDA for Its MagicTouch Sirolimus Coated Balloon
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 16 Apr 2019
Aprea Therapeutics Receives FDA Fast Track Designation and Orphan Drug Designation for APR-246 for the Treatment of Myelodysplastic Syndromes (MDS)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Apr 2019
Daiichi Sankyo Provides Update on Ongoing FDA Review for Quizartinib for Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Apr 2019
ExsoMed appoints William E. Maya as Chief Executive Officer
Devices Orthopaedic Personnel
 HSMN NewsFeed - 27 Mar 2019
Novartis receives FDA approval for Mayzent(R) (siponimod), the first oral drug to treat secondary progressive MS with active disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 26 Mar 2019
Breath Therapeutics Announces Initiation of Global Phase 3 Trials for the Treatment of Bronchiolitis Obliterans Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 14 Mar 2019
BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease
Devices Interventional FDA
 HSMN NewsFeed - 6 Mar 2019
Ampio Updates Regulatory Status for Ampion
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Mar 2019
MedShape Announces Commercial Launch of DynaClip(TM) Bone Staple
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 27 Feb 2019
Aprea Therapeutics Adds New Investor to Series C Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 19 Feb 2019
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
Biopharmaceuticals
 HSMN NewsFeed - 12 Feb 2019
U.S. FDA Approves DARZALEX(R) (daratumumab) Split-Dosing Regimen
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Jan 2019
U.S. FDA Approves IMBRUVICA(R) (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination Regimen for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Jan 2019
Actinium Pharmaceuticals Appoints Accomplished Industry Executive Cynthia Pussinen as Executive Vice President of Technical Operations and Supply Chain
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Jan 2019
European Commission Approves BLINCYTO(R) (blinatumomab) In Patients With Philadelphia Chromosome Negative Minimal Residual Disease-Positive B-cell Precursor Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 16 Jan 2019
Abbott To Acquire Cephea Valve Technologies, Inc.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 10 Jan 2019
Astellas Announces Key Senior Leadership Promotions and New Hire in Medical and Development Organization
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Dec 2018
PharmaEssentia and AOP Orphan Receive Positive CHMP Opinion For Besremi(TM) (Ropeginterferon alfa-2b) For Treatment Of Polycythemia Vera (PV) In EU
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 13 Dec 2018
Ampio Updates Regulatory Status for Ampion
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Dec 2018
Janssen Affiliate Cilag GmbH International Enters Worldwide Collaboration and License Agreement with argenx for Cancer Immunotherapy Cusatuzumab
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 20 Nov 2018
FDA Approves Gamifant(R) (emapalumab), the First and Only Treatment for Primary Haemophagocytic Lymphohistiocytosis (HLH)
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Nov 2018
EMA Validates and Grants Accelerated Assessment of Marketing Authorization Application for Daiichi Sankyo's FLT3 Inhibitor Quizartinib for Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 1 Nov 2018
AbbVie Receives European Commission Approval of VENCLYXTO(R) (venetoclax) Plus Rituximab for the Treatment of Patients with Chronic Lymphocytic Leukemia Who Have Received at Least One Prior Therapy
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 31 Oct 2018
Shavit Capital Completes $100 Million Investment Round for Its Fifth Fund
Biopharmaceuticals Devices Venture Capital
 HSMN NewsFeed - 30 Oct 2018
U.S. FDA Approves INVOKANA(R) (canagliflozin) to Reduce the Risk of Heart Attack, Stroke or Cardiovascular Death in Adults with Type 2 Diabetes and Established Cardiovascular Disease
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 18 Oct 2018
Positive Results of Orthopedic Treatment With the Use of ApoGraft(TM) Enriched Stem Cells Derived From Fat Tissues
Regenerative Medicine Orthopaedic
 HSMN NewsFeed - 17 Oct 2018
AbbVie Announces Supplemental New Drug Application Accepted for Priority Review by U.S. FDA for IMBRUVICA(R) (ibrutinib) in Combination with Obinutuzumab (GAZYVA(R)) for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Oct 2018
FDA Approves Stiolto(R) Respimat(R) Supplemental New Drug Application (sNDA) to Add Data on COPD Exacerbation Reduction
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 1 Oct 2018
First Patient Enrolled in Vertos Medical's New MOTION Study of MILD(R) Procedure, a Minimally Invasive Treatment for Lumbar Spinal Stenosis
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 11 Sep 2018
Vertos Medical Announces MILD(R) Procedure Long-term Safety and Efficacy Data
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 4 Sep 2018
Genoptix Launches FDA-Authorized BCR-ABL MRDx(R) TFR Monitoring Test for Patients with Chronic Myeloid Leukemia on Tasigna(R) (nilotinib)
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 29 Aug 2018
European Commission Approves BLINCYTO(R) (blinatumomab) For Use In Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 29 Aug 2018
Trovagene Announces European Commission Grants Orphan Drug Designation to Onvansertib (PCM-075) for Treatment of Acute Myeloid Leukemia in Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 27 Aug 2018
Cantex Pharmaceuticals, Inc. Receives FDA Fast Track Designation For CX-01 For The Treatment Of Patients Over Age 60 With Newly Diagnosed Acute Myeloid Leukemia (AML)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Aug 2018
AbbVie Announces IMBRUVICA(R) (ibrutinib) Plus Rituximab Approval by U.S. FDA as First Chemotherapy-Free Combination Treatment in Adults with Waldenström's Macroglobulinemia, a Rare Type of Blood Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Aug 2018
Vyxeos(R) Receives Marketing Authorisation in the European Union for Treatment of Certain Types of High-Risk Acute Myeloid Leukaemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 20 Aug 2018
Q BioMed Inc. Announces FDA Filing for Strontium Chloride Sr89 Injection USP for Relief of Metastatic Cancer Bone Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Aug 2018
Rockwell Medical Appoints New Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Aug 2018
Janssen Submits U.S. & EU Regulatory Applications Seeking Approval of DARZALEX(R) (daratumumab) Split Dosing Regimen
Biopharmaceuticals Oncology FDA Regulatory
 HSMN NewsFeed - 1 Aug 2018
FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo's FLT3 Inhibitor Quizartinib for Relapsed/Refractory FLT3-ITD AML
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Jul 2018
Accord Healthcare’s (Intas) Pelgraz(R) (pegfilgrastim) Given Green Light by CHMP
Biopharmaceuticals Generics Oncology Regulatory
 HSMN NewsFeed - 25 Jul 2018
Addenbrooke's Hospital is First in the UK to Treat Cancer Patients with Accuray Radixact(R) System
Devices Oncology Product Launch
 HSMN NewsFeed - 20 Jul 2018
FDA Grants Approval of TIBSOVO(R), the First Oral, Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH1 Mutation
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Jul 2018
Laminate Medical Technologies announces first forearm fistula cases in Germany
Devices
 HSMN NewsFeed - 17 Jul 2018
Ascentage Pharma Raises $150 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Jul 2018
New England Journal of Medicine Publishes Results from Pivotal Study of TEGSEDI(TM) (inotersen) for the Treatment of Hereditary ATTR Amyloidosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Jun 2018
BrainStorm Strengthens Executive Management Team with the Appointment of Susan Ward, Ph.D. and Joseph Petroziello
Regenerative Medicine Personnel
 HSMN NewsFeed - 21 Jun 2018
Accuray Receives AERB Approval for Sale and Supply of its Radixact(R) X9 System in India
Devices Oncology Regulatory
 HSMN NewsFeed - 15 Jun 2018
Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons
Devices Interventional FDA
 HSMN NewsFeed - 15 Jun 2018
AbbVie Announces New Undetectable Minimal Residual Disease Data from Phase 3 Relapsed/Refractory Chronic Lymphocytic Leukemia MURANO Trial of Venetoclax in Combination with Rituximab at 23rd European Hematology Association Annual Congress
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Jun 2018
NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 6 Jun 2018
Partner Therapeutics (PTx) Announces US FDA Approval of Leukine(R) (sargramostim) for the Treatment of Acute Radiation Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 May 2018
FDA expedites review of Novartis drug Promacta(R) for first-line severe aplastic anemia (SAA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 May 2018
U.S. FDA Grants Priority Review to Astellas' New Drug Application for Gilteritinib for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 May 2018
IMBRUVICA(R) (ibrutinib) Plus GAZYVA(R) (obinutuzumab) Phase 3 iLLUMINATE Trial for First-Line Therapy of Chronic Lymphocytic Leukemia (CLL) Patients Met Primary Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 May 2018
Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 22 May 2018
Five-Year Study Data Confirm Positive Outcomes for Patients When Abbott Diagnostic Tool Was Used to Guide Heart Stenting Decisions
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2018
TapImmune Creates Scientific Advisory Board to Support Clinical Development of Multi-Antigen Cell Therapy Platform
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 May 2018
Daiichi Sankyo Announces Single Agent Quizartinib Significantly Prolongs Overall Survival Compared with Chemotherapy in Patients with Relapsed/Refractory AML with FLT3-ITD Mutations (QuANTUM-R Study)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Apr 2018
Ampio Updates Regulatory, Clinical and NYSE Activities
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Apr 2018
Duchesnay USA Announces Launch of Bonjesta(R) (doxylamine succinate - pyridoxine hydrochloride) in the United States
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 21 Mar 2018
TCR2 Therapeutics Raises $125 Million in Oversubscribed Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 21 Mar 2018
BrainStorm Appoints Two Leading Thought Leaders in the Fields of Neuroscience and Regenerative Medicine to its Scientific Advisory Board
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 20 Mar 2018
Mylan Adds to Growing Oncology Portfolio with Launch of Generic Mutamycin(R) Injection
Biopharmaceuticals Generics Oncology Product Launch
 HSMN NewsFeed - 16 Mar 2018
Q Biomed Inc. Announces FDA Filing for Approval of a New Manufacturing Facility for Non-Opioid Strontium Chloride SR89 Injection USP for Relief of Cancer Bone Pain
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Mar 2018
Ionis and Akcea Partner to Commercialize Inotersen for hATTR
Biopharmaceuticals Licensing
 HSMN NewsFeed - 9 Mar 2018
CTI BioPharma Announces Publication of Pacritinib Phase 3 PERSIST-2 Clinical Trial in JAMA Oncology
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Mar 2018
BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2017
Regenerative Medicine Neurology
 HSMN NewsFeed - 27 Feb 2018
Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta(R) (pegfilgrastim)
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 23 Feb 2018
Amgen Receives Positive Opinion Expanding Use Of XGEVA(R) (denosumab) To Cover Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma In Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 Feb 2018
ZYTIGA(R) (abiraterone acetate) Plus Prednisone Approved for Treatment of Earlier Form of Metastatic Prostate Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Feb 2018
Trethera Corporation Announces FDA Clearance of Investigational New Drug Application for TRE-515
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Feb 2018
BrainStorm Cell Therapeutics Appoints Senior Kite Executive, Anthony Polverino, Ph.D., to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 1 Feb 2018
Partner Therapeutics (PTx) Acquires Leukine(R) from Sanofi
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 29 Jan 2018
gammaCore(R) Receives FDA Clearance for the Acute Treatment of Pain Associated with Migraine Headache in Adult Patients
Devices Neurology FDA
 HSMN NewsFeed - 15 Jan 2018
USRM Reaches Key Sales Milestone of Proprietary Adipocell(TM) Product
Regenerative Medicine
 HSMN NewsFeed - 11 Jan 2018
Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 5 Jan 2018
FDA Approves XGEVA(R) (denosumab) For The Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Jan 2018
Novartis drug Promacta(R) receives FDA Breakthrough Therapy designation for first-line use in severe aplastic anemia (SAA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Dec 2017
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 15 Dec 2017
Egalet Receives FDA Tentative Approval for Expanded Label for ARYMO(R) ER (morphine sulfate) C-II, an Extended-Release Morphine Product Formulated with Abuse-Deterrent Properties for Treatment of Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Dec 2017
DARZALEX(R) (daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Dec 2017
Forty Seven Inc. Receives $5 Million Grant from The California Institute for Regenerative Medicine (CIRM) to Support Ongoing Clinical Trial in Acute Myeloid Leukemia
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 5 Dec 2017
INVOKANA(R) (canagliflozin) Significantly Improved Renal Outcomes and Demonstrated Potential Renal Protective Effects in Patients with Type 2 Diabetes Who Have or Are at Risk for Cardiovascular Disease
Biopharmaceuticals Nephrology
 HSMN NewsFeed - 30 Nov 2017
Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 29 Nov 2017
electroCore Completes $70 Million Series B Funding Round
Devices Neurology Venture Capital
 HSMN NewsFeed - 22 Nov 2017
Ampio Announces Publication of Ampion(TM) Treatment of Severe Osteoarthritis of the Knee as a Feature Article in Orthopedics Peer-Reviewed Journal
Biopharmaceuticals Orthopaedic
 HSMN NewsFeed - 20 Nov 2017
U.S. FDA Approves Kaléo's AUVI-Q(R) (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children
Biopharmaceuticals Devices Drug Delivery FDA
 HSMN NewsFeed - 13 Nov 2017
PlaqueTec Announces the Appointment of Annalisa Jenkins, MBBS, FRCP, as Chief Executive Officer
Devices Diagnostics Cardiology Personnel
 HSMN NewsFeed - 10 Nov 2017
Amgen Receives Positive CHMP Opinion To Expand Use Of Nplate(R) (romiplostim) In Pediatric Patients With Chronic Immune Thrombocytopenic Purpura
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 2 Nov 2017
BrainStorm Strengthens Executive Team: Appoints Eyal Rubin as Chief Financial Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 30 Oct 2017
Abbott Introduces Next Generation of Most Widely Used Heart Stent for People with Coronary Artery Disease in Europe[1]
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 25 Oct 2017
Cellect Announces a Major Breakthrough of its ApoGraft(TM) Technology: Reporting Today Positive Results from a 20 Patients Trial With Tel-Aviv Ichilov Medical Center
Regenerative Medicine
 HSMN NewsFeed - 16 Oct 2017
BrainStorm Enrolls First Patients in Phase 3 Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology
 HSMN NewsFeed - 14 Sep 2017
Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Sep 2017
electroCore Announces Results from gammaCore(R) (non-invasive vagus nerve stimulator) Study in Migraine at the 18th Congress of the International Headache Society
Devices Neurology
 HSMN NewsFeed - 6 Sep 2017
Pulmatrix Licenses Inhaled COPD Drug PUR0200 to Vectura Group plc
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Sep 2017
FDA Grants Orphan Drug Status to Cellect's ApoGraft(TM) for Acute GvHD and Chronic GvHD
Regenerative Medicine FDA
 HSMN NewsFeed - 1 Sep 2017
FDA approves Mylotarg for treatment of acute myeloid leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Aug 2017
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Aug 2017
Philips and HeartFlow Announce Global Collaboration Agreement
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Aug 2017
Getinge announces full U.S. availability of Pulsar(R)-18 self-expanding stent from BIOTRONIK for patients with peripheral artery disease
Devices Interventional Product Launch
 HSMN NewsFeed - 21 Aug 2017
Gamida Cell Announces First Patient Transplanted in Phase 1/2 Study of CordIn for Severe Aplastic Anemia and Hypoplastic MDS
Biopharmaceuticals
 HSMN NewsFeed - 9 Aug 2017
Ocugen Receives FDA Orphan Drug Designation for OCU300 (brimonidine tartrate) for the Treatment of Ocular Graft Versus Host Disease
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 7 Aug 2017
BrainStorm Supports Commitment to ALS Patient Community with Appointment of a Vice President of Patient Advocacy and Government Affairs
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 27 Jul 2017
U.S. FDA Grants Priority Review for an Epinephrine Auto-Injector in Development by Kaléo Specifically for Infants and Small Children
Biopharmaceuticals Devices Drug Delivery FDA
 HSMN NewsFeed - 25 Jul 2017
BrainStorm Announces Agreement with University of California Irvine Medical Center to Participate in Phase 3 Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology
 HSMN NewsFeed - 21 Jul 2017
Brainstorm Awarded $16 Million Non-Dilutive Grant from CIRM in Support of Phase 3 Clinical Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology
 HSMN NewsFeed - 18 Jul 2017
BrainStorm Announces Agreements with Mass. General Hospital and California Pacific Medical Center to Participate in Phase 3 Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology
 HSMN NewsFeed - 11 Jul 2017
Neuro Spinal Hospital in Dubai to Acquire Accuray CyberKnife(R) and Radixact(TM) Systems
Devices Oncology Neurosurgery
 HSMN NewsFeed - 10 Jul 2017
Gamida Cell Inc. Names Ronit Simantov, M.D. as Chief Medical Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 6 Jul 2017
IsoRay Receives FDA Response to 510(k) Application for GammaTile(TM)
Devices Oncology FDA
 HSMN NewsFeed - 20 Jun 2017
IUCT Oncopole Advances Cancer Care in France with the New Accuray Radixact(TM) System
Devices Oncology
 HSMN NewsFeed - 19 Jun 2017
FDA Accepts Amgen's Supplemental Biologics License Application To Expand Indication For XGEVA(R) (denosumab) To Include Multiple Myeloma Patients
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Jun 2017
Vertos Medical Secures $28 Million In Latest Round Of Funding
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 5 Jun 2017
Gamida Cell Appoints Nobel Prize Laureate Professor Roger Kornberg and Immune Oncology Expert Dr. Michael Perry to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jun 2017
New Data Presented at ASCO 2017 Finds IMBRUVICA(R) (ibrutinib) May Offer a More Targeted Approach to Chronic Lymphocytic Leukemia (CLL) Treatment than Chemotherapy Agent Chlorambucil in Treatment-Naïve Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 May 2017
Boston Scientific Announces Positive Outcomes From Prospective Study Of Bronchial Thermoplasty
Devices
 HSMN NewsFeed - 2 May 2017
Medeon Biodesign Announces Approval to Begin CE Clinical Study for the XPro(TM) Large Bore Vascular Closure System
Devices Interventional Regulatory
 HSMN NewsFeed - 1 May 2017
Ampio Initiates Pivotal Trial of Ampion(TM)
Biopharmaceuticals Orthopaedic
 HSMN NewsFeed - 28 Apr 2017
Novartis Receives FDA Approval for Rydapt(R) in Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML) and Three Types of Systemic Mastocytosis (SM)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Apr 2017
FDA Approves XATMEP(TM), the First and Only Ready-To-Use Methotrexate Oral Solution
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Apr 2017
Mercator MedSystems Announces First Enrollment in the TANGO Trial for BTK Vascular Disease
Devices Interventional Drug Delivery
 HSMN NewsFeed - 26 Apr 2017
Asterias Announces Publication of Positive Phase 2 Data on AST-VAC1 for the Treatment of Acute Myeloid Leukemia (AML) in 'Cancer'
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 18 Apr 2017
FDA Releases gammaCore(R), the First Non-Invasive Vagus Nerve Stimulation Therapy Applied at the Neck for Acute Treatment of Pain Associated with Episodic Cluster Headache in Adult Patients
Devices FDA
 HSMN NewsFeed - 11 Apr 2017
First Cancer Patients in Africa Treated with the TomoTherapy(R) System
Devices Oncology
 HSMN NewsFeed - 5 Apr 2017
First U.S. Patient Treated in Landmark Vascular Study of Lithoplasty(R) Technology
Devices Interventional
 HSMN NewsFeed - 22 Mar 2017
Moleculin Receives Orphan Drug Designation for Annamycin for the Treatment of Acute Myeloid Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Mar 2017
Teleflex (TFX) Announces 510(k) Clearance and Global Launch of Twin-Pass(R) Torque Dual Access Catheter
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 14 Mar 2017
Teleflex (TFX) Announces 510(k) Clearance and U.S. Launch of Spectre(TM) Guidewire
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 13 Mar 2017
Spineology(R) Announces Expanded FDA Clearance of Elite(TM) Expandable Interbody Fusion System
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 13 Mar 2017
Lycera Announces the Appointment of Pablo J. Cagnoni, M.D., to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Mar 2017
BrainStorm Strengthens Management Team with Appointment of Ralph Z. Kern, MD, MHSc as Chief Operating Officer and Chief Medical Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 2 Mar 2017
BLINCYTO(R) (blinatumomab) Significantly Improved Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Compared To Chemotherapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Feb 2017
BrainStorm Names Dr. June S. Almenoff and Arturo O. Araya to its Board of Directors as Company Prepares for Clinical and Commercial Success
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 24 Feb 2017
CHMP Issues Positive Opinion Recommending DARZALEX(R) (daratumumab) for Relapsed or Refractory Multiple Myeloma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 21 Feb 2017
BrainStorm Seeking Approval To Distribute NurOwn(R) in Canada
Regenerative Medicine Neurology Regulatory Distribution
 HSMN NewsFeed - 21 Feb 2017
Actinium Pharmaceuticals Announces Hiring of Steven Price to Position of Vice President, Clinical and Commercial Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Feb 2017
LYNPARZA(TM) (olaparib) Meets Primary Endpoint in Phase III Trial in BRCA-Mutated Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Feb 2017
FDA Expands Approval of SPIRIVA(R) RESPIMAT(R) (tiotropium bromide) Inhalation Spray for Maintenance Treatment of Asthma in Children
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Feb 2017
NICE Guidance Recommends HeartFlow FFRct Analysis to Help Determine Cause of Stable Chest Pain in Patients
Devices Diagnostics Cardiology
 HSMN NewsFeed - 8 Feb 2017
Zimmer Biomet Announces the International Release of the Innovative Subchondroplasty(R) Procedure
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 7 Feb 2017
Argon Medical Devices, Inc., Sells Critical Care Platform to Merit Medical Systems, Inc.
Devices Interventional Acquisitions
 HSMN NewsFeed - 2 Feb 2017
Vividion Therapeutics, Inc., Launches With $50 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 31 Jan 2017
Paragon 28 announces launch of unprecedented small bone fixation system for foot & ankle-Baby Gorilla Mini Plating System
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 25 Jan 2017
Vioguard Secures $5MM Series A Financing Round Led by Imagen Capital Partners
Devices Venture Capital
 HSMN NewsFeed - 20 Jan 2017
Verastem Announces Executive Leadership Appointments and Changes
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Jan 2017
Abbott Completes the Acquisition of St. Jude Medical
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 28 Nov 2016
Conditional Approval from the European Commission to Treat Multiple Myeloma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Nov 2016
DARZALEX(R) (daratumumab) Approved by U.S. FDA in Combination with Two Standard of Care Regimens for the Treatment of Patients with Multiple Myeloma Who Have Received At Least One Prior Therapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Nov 2016
Gamida Cell Names Julian Adams, Ph.D. New Chairman of the Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Nov 2016
IBRANCE(R) (palbociclib) Receives Approval in European Union for the Treatment of Women with HR+/HER2- Metastatic Breast Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 Nov 2016
Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Valeant for Contrave(R) (naltrexone HCl / bupropion HCl extended release) in Australia and New Zealand
Biopharmaceuticals Distribution
 HSMN NewsFeed - 26 Oct 2016
Actinium Pharmaceuticals Announces New Hires As Supply Chain Organization Expands To Accommodate Growth
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Oct 2016
InspireMD Announces Independent Study Published in the Journal of Endovascular Therapy That Continues to Support the Clinical Benefit and Utility of the CGuard Embolic Prevention System
Devices Interventional
 HSMN NewsFeed - 17 Oct 2016
Teleflex Receives FDA Clearance for the Arrow(R) Midline with Chlorag+ard(R) Technology
Devices FDA
 HSMN NewsFeed - 17 Oct 2016
Teva Receives Positive Opinion from European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) to Extend Indication of Trisenox(R) for First Line Treatment of Low- to Intermediate Risk Acute Promyelocytic Leukemia (APL)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Oct 2016
St. Jude Medical Announces FDA Clearance and Launch of the New PressureWire X Guidewire Designed to Optimize PCI Procedures in Patients With Complex Anatomies
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 10 Oct 2016
Teleflex Receives FDA Clearance for ARROW(R)JACC with Chlorag+ard(R) Technology and Tunneler
Devices FDA
 HSMN NewsFeed - 5 Oct 2016
Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor
Biopharmaceuticals Licensing
 HSMN NewsFeed - 30 Sep 2016
Threshold Pharmaceuticals Announces Interim Results from Tarloxotinib Program and its Plans to Focus on Evofosfamide and Earlier-Stage Opportunities
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Sep 2016
Amgen And Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Sep 2016
Monteris Medical Receives IDE Approval From FDA To Evaluate NeuroBlate(R) In Patients Newly Diagnosed With Glioblastoma Multiforme
Devices Oncology Neurosurgery FDA
 HSMN NewsFeed - 5 Sep 2016
New Data: STIOLTO(R) RESPIMAT(R) (tiotropium bromide+olodaterol) Inhalation Spray Significantly Improved Exercise Capacity in People with COPD
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 31 Aug 2016
XALKORI(R) (Crizotinib) Receives Approval In European Union For The Treatment Of Patients With ROS1-Positive Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 12 Aug 2016
Arrowhead Pharmaceuticals Closes $45 Million Private Offering
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Aug 2016
Takeda Receives Marketing Authorization in Canada for NINLARO(TM) (ixazomib) in Relapsed/Refractory Multiple Myeloma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 7 Jul 2016
Shire Receives Extension of Market Authorization in Europe for Revestive(R) (Teduglutide) for the Treatment of Paediatric Patients with Short Bowel Syndrome (SBS)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 29 Jun 2016
AbbVie Announces Fourth Breakthrough Therapy Designation Granted by the U.S. Food and Drug Administration (FDA) for Ibrutinib (IMBRUVICA(R)) for Chronic Graft-Versus-Host-Disease (cGVHD), a Rare Condition with Limited Treatment Options
Biopharmaceuticals
 HSMN NewsFeed - 17 Jun 2016
ARIAD Announces Distribution Agreements for Iclusig(R) in Latin America and the Middle East/North Africa
Biopharmaceuticals Distribution
 HSMN NewsFeed - 16 Jun 2016
Pernix Therapeutics Announces Positive Phase IV Results of Silenor(R) vs. Zolpidem Head-to-Head Arousability Study
Biopharmaceuticals
 HSMN NewsFeed - 9 Jun 2016
NUEDEXTA(R) Effective for Pseudobulbar Affect (PBA) in Patients with Alzheimer's Disease and other Dementias, Stroke and Traumatic Brain Injury
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Jun 2016
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 6 Jun 2016
Celator Pharmaceuticals(R) Presented Phase 3 Trial Results in Patients with High-Risk Acute Myeloid Leukemia Demonstrating VYXEOS(TM) (CPX-351) Significantly Improved Overall Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 May 2016
St. Jude Medical Announces European Launch of the Latest in PressureWire Guidewire Technology to Measure Pressure Differences Across Narrowed Coronary Arteries
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 13 May 2016
Impulse Dynamics Completes $30 Million Financing Round
Devices Cardiology Venture Capital
 HSMN NewsFeed - 12 May 2016
FDA Clears Next-Generation Version of EndoGastric Solutions’ EsophyX(R) Device
Devices Gastroenterology FDA
 HSMN NewsFeed - 11 May 2016
Regen BioPharma, Inc. Discusses Recent Developments in Aplastic Anemia Therapy and Future Potential Expansion of HemaXellerate
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 28 Apr 2016
Teleflex Signs New Agreements with HealthTrust for LMA(R) Airways and Arrow(R) Pain Management Solutions
Devices Group Purchasing
 HSMN NewsFeed - 5 Apr 2016
Pfizer Announces Positive Top-Line Results from the First Phase 3 Trial of Investigational Tofacitinib in Adults with Psoriatic Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 31 Mar 2016
Vivex Biomedical, Inc. and Arthrex, Inc. Enter into Long Term Agreement
Devices Orthopaedic
 HSMN NewsFeed - 24 Mar 2016
Pivotal Phase III Trial of enzalutamide Initiated in Metastatic Hormone Sensitive Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Mar 2016
Threshold Pharmaceuticals Appoints Stew Kroll as Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Mar 2016
Kris Peterson to Join Paratek Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2016
Asana Medical, Inc. Names Dr. Christine V. Sapan CEO, Adds University of Miami's Sergio M. Gonzalez to Its Board of Directors
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 29 Feb 2016
Genentech Provides Update On Two Identical Phase III Studies Of Lebrikizumab In People With Severe Asthma
Biopharmaceuticals
 HSMN NewsFeed - 26 Feb 2016
AbbVie Receives EMA Orphan Drug Designation for Investigational Compound Venetoclax for the Treatment of Acute Myeloid Leukemia (AML)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Feb 2016
Boston Scientific Receives CE Mark For Eluvia(TM) Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial
Devices Interventional Regulatory Product Launch
 HSMN NewsFeed - 17 Feb 2016
New OneTouch Verio Flex(TM) Blood Glucose Meter Takes the Guesswork Out of Blood Sugar Test Results
Devices Monitoring Endocrinology Product Launch
 HSMN NewsFeed - 17 Feb 2016
BD Receives FDA 510(k) Clearance for New Blood Collection Device to Help Enhance Patient and Clinician Experience
Devices FDA
 HSMN NewsFeed - 4 Feb 2016
Phase 3 Study of BLINCYTO(R) (Blinatumomab) Met Primary Endpoint Of Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Jan 2016
Venetoclax Receives 3rd Breakthrough Therapy Designation from the FDA for the Combination Treatment of Patients with Untreated Acute Myeloid Leukemia not Eligible for Standard Induction Chemotherapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Jan 2016
AbbVie's Venetoclax Receives Breakthrough Therapy Designation from FDA in Combination with Rituximab for the Treatment of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Jan 2016
Impax Receives Approval of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Jan 2016
Smith & Nephew acquires first-line cartilage repair product
Devices Orthopaedic Acquisitions
 HSMN NewsFeed - 11 Jan 2016
FDA Approves Animas(R) Vibe(R) Insulin Pump and Continuous Glucose Monitoring System For Use in Children
Devices Endocrinology Monitoring FDA
 HSMN NewsFeed - 11 Jan 2016
MedLumics Appoints Cardiovascular Device Expert Tim Lenihan to Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 11 Jan 2016
Teleflex Acquisition of Nostix, LLC Expands Catheter Tip Placement Solutions
Devices Mergers & Acquisitions
 HSMN NewsFeed - 28 Dec 2015
Chimerix Announces Top-Line Results From Phase 3 SUPPRESS Trial of Brincidofovir
Biopharmaceuticals
 HSMN NewsFeed - 14 Dec 2015
Antares Pharma Announces FDA Approval of Sumatriptan Injection USP
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Dec 2015
Merck KGaA, Darmstadt, Germany, Decides Not to Pursue Evofosfamide Further in Soft Tissue Sarcoma and Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Dec 2015
BrainStorm Cell Therapeutics Announces Appointment of Dr. Revital Geffen-Aricha as Vice President of Research & Development
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 2 Dec 2015
Cesca Receives Approval for Medicare Coverage
Regenerative Medicine Reimbursement
 HSMN NewsFeed - 25 Nov 2015
Pfizer Receives European Approval to Expand Use of XALKORI(R) (crizotinib) to First-Line Treatment of Adults with ALK-Positive Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 Nov 2015
European Commission Approves Amgen's BLINCYTO(R) (blinatumomab) for the Treatment of Adults with Philadelphia Chromosome-Negative Relapsed or Refractory B-precursor Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 18 Nov 2015
Pfizer Reports Positive Topline Results from Phase 3 Trial Comparing XALKORI(R) (crizotinib) to Chemotherapy in Previously Untreated East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Nov 2015
Otonomy Initiates Patient Enrollment in U.S. Phase 3 Clinical Trial of OTO-104 in Meniere's Disease
Biopharmaceuticals
 HSMN NewsFeed - 9 Nov 2015
Eiger BioPharmaceuticals Announces License Agreement with Nippon Kayaku to Develop Bestatin(TM) (ubenimex) for Inflammatory Diseases Involving LTB4
Biopharmaceuticals Licensing
 HSMN NewsFeed - 2 Nov 2015
New CyberKnife(R) and TomoTherapy(R) System Data Presented at Leading Scientific Industry Meeting
Devices Oncology
 HSMN NewsFeed - 30 Oct 2015
Celgene’s VIDAZA(R) (Azacitidine for Injection) Approved by the European Commission as New Treatment for Elderly Patients with Acute Myeloid Leukaemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 26 Oct 2015
Michael Bruch Appointed Chief Financial Officer of Cesca Therapeutics
Regenerative Medicine Personnel
 HSMN NewsFeed - 23 Oct 2015
Teleflex Introduces LMA Protector(TM) Airway, a New Standard in LMA(R) Airway Management Devices
Devices Surgery Product Launch
 HSMN NewsFeed - 23 Oct 2015
Spectrum Pharmaceuticals Receives Complete Response Letter (CRL) from U.S. Food and Drug Administration (FDA) for EVOMELA(TM) (melphalan) for Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Oct 2015
EndoGastric Solutions Announces New Sham-Controlled European Study Demonstrates Transoral Incisionless Fundoplication (TIF) Procedure as Effective Alternative for Daily PPI Treatment
Devices Gastroenterology
 HSMN NewsFeed - 14 Oct 2015
Benvenue Medical Announces Commercial Availability of Luna(R) 3D Interbody Fusion System, 2015 Spine Technology Award
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 12 Oct 2015
Abbott Announces Positive Clinical Results of Absorb(TM), the Naturally Dissolving Heart Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Oct 2015
OptiNose Closes New Round of Financing
Devices Drug Delivery Venture Capital
 HSMN NewsFeed - 25 Sep 2015
Celgene’s VIDAZA(R) (Azacitidine for Injection) Receives Positive CHMP Opinion as New Treatment for Elderly Patients with Acute Myeloid Leukaemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 18 Sep 2015
St. Jude Medical Gains CE Mark for 27mm & 29mm Portico TAVR Valves to Complete a Full Portfolio of Portico Sizing Options for Physicians Treating Patients with Aortic Stenosis
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 15 Sep 2015
Zimmer Biomet Announces Release of Innovative Subchondroplasty(R) Procedure for Foot and Ankle Surgery
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 10 Sep 2015
Lori Kunkel, M.D., Joins Tocagen's Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Sep 2015
Rockwell Medical Announces the U.S. Commercial Launch of Triferic(TM)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 17 Aug 2015
European Commission Grants Marketing Authorisation for Unituxin(TM) (dinutuximab) for the Treatment of Paediatric High-Risk Neuroblastoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 13 Aug 2015
Cantex Pharmaceuticals Enhances Executive Management Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Aug 2015
Rich Pharmaceuticals, Inc. Appoints Richard Salvador, Ph.D., Research & Development Expert, To Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Aug 2015
BrainStorm Strengthens Executive Team: Announces the Appointment of Yoram Bibring as Chief Financial Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 27 Jul 2015
European Medicines Agency Validates and Grants Accelerated Assessment of Marketing Authorization Application for Empliciti (elotuzumab) For the Treatment of Multiple Myeloma in Patients Who Have Received One or More Prior Therapies
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 14 Jul 2015
New TomoTherapy(R) System Data Presented at Leading Scientific Industry Meeting
Devices Oncology
 HSMN NewsFeed - 14 Jul 2015
Transgenomic Launches Most Comprehensive Genetic Test for Diagnosis of Leukodystrophy
Diagnostics Product Launch
 HSMN NewsFeed - 22 Jun 2015
Vaxil's Lead Product ImMucin has Been Granted an Orphan Drug Designation by the FDA for the Treatment of Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Jun 2015
Dutch Hospital Acquires 1,000th Agility, Elekta's Radiotherapy Beam-shaping Technology for Treating Cancer
Devices Oncology
 HSMN NewsFeed - 16 Jun 2015
ZS Pharma Names Jeffrey Farrow as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jun 2015
FH Ortho Receives FDA 510(k) Clearance for Its CALCAnail(R) Orthopedic Arthrodesis Nail
Devices Orthopaedic FDA
 HSMN NewsFeed - 12 Jun 2015
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Jun 2015
Cesca Therapeutics Board of Directors Appoint Robin C. Stracey as Chief Executive Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 20 May 2015
Post-Market Study Evaluating The Boston Scientific Lotus(TM) Valve System Demonstrates Extremely Low PVL Rates
Devices Interventional Cardiology
 HSMN NewsFeed - 19 May 2015
Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 14 May 2015
InVivo Therapeutics Reports Update of First Two Spinal Cord Injury Patients Implanted with Neuro-Spinal Scaffold
Devices Neurosurgery
 HSMN NewsFeed - 13 May 2015
Jeng-Dar Yang Ph.D. Joins Actinium Pharmaceuticals as Vice President of Pharmaceutical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 May 2015
Merck KGaA, Darmstadt, Germany, Receives FDA Fast Track Designation for Evofosfamide for the Treatment of Patients Living With Advanced Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Apr 2015
Horizon Pharma plc Receives FDA Fast Track Designation for ACTIMMUNE(R) in the Treatment of Friedreich's Ataxia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 2 Apr 2015
Ethicon’s HARMONIC FOCUS(R)+ Shears Now Proven to Produce Vessel Seal Strength Equivalent to Advanced Bipolar Devices
Devices Surgery
 HSMN NewsFeed - 1 Apr 2015
InVivo Therapeutics Announces New Clinical Trial Site for Neuro-Spinal Scaffold
Devices Neurosurgery Neurology
 HSMN NewsFeed - 19 Mar 2015
Coronado Biosciences Announces the Formation of Mustang Therapeutics, Inc. in Partnership With the City of Hope in Duarte, CA
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Mar 2015
Tryton Medical Announces Publication of Data from Pivotal Trial for Tryton Side Branch Stent in Journal of American College of Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Feb 2015
BioRestorative Therapies Announces the Appointment of Edward Field as President of the brtxDISC(TM) Division
Regenerative Medicine Orthopaedic Personnel
 HSMN NewsFeed - 17 Feb 2015
Dallen Medical Receives FDA Clearance for New Tensyn(TM) Plug
Devices Orthopaedic FDA
 HSMN NewsFeed - 13 Feb 2015
Horizon Pharma plc Submits Investigational New Drug Application for ACTIMMUNE(R) in the Treatment of Friedreich's Ataxia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 13 Feb 2015
Entellus Medical Announces Release of XprESS(TM) Ultra Multi-Sinus Dilation System
Devices Product Launch
 HSMN NewsFeed - 4 Feb 2015
First TomoTherapy(R) System in Latin America Dedicated Solely to Breast Cancer Care Now Treating Patients
Devices Radiology Oncology
 HSMN NewsFeed - 13 Jan 2015
Teleflex Incorporated Highlights Article on ARROW(R) VPS(R) Vascular Positioning System, Showing Significant Reduction in Catheter Malpositions
Devices
 HSMN NewsFeed - 13 Jan 2015
Teleflex Reports Study Results of ARROWg+ard(R) Technology Effectiveness in Preventing Infections and Associated Costs in an Infection-Prone Insertion Site
Devices
 HSMN NewsFeed - 13 Jan 2015
Teleflex Awarded HealthTrust Agreement for Peripherally Inserted Central Catheter (PICC) Products
Devices Group Purchasing
 HSMN NewsFeed - 26 Nov 2014
Cardio3 BioSciences Announces the Nomination of Three Co-principal Investigators for its CHART-2 Phase III Clinical Trial of C-Cure(R) for the Treatment of Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 19 Nov 2014
Argon Medical's CLEANER XT(TM) and CLEANER 15(TM) Rotational Thrombectomy Systems Receive FDA Clearance for Mechanical Declotting and Infusion in the Peripheral Vasculature
Devices Interventional FDA
 HSMN NewsFeed - 18 Nov 2014
Intellia Therapeutics Announces $15 Million in Funding to Develop Therapeutic Products Utilizing CRISPR-Cas9 Gene Editing Technology
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Nov 2014
BioCardia(R), Inc. Announces FDA Acceptance of Phase III Clinical Trial Protocol Studying Bone Marrow-Derived Cell Therapy for Heart Failure Patients
Regenerative Medicine Cardiology FDA
 HSMN NewsFeed - 28 Oct 2014
Dallen Medical Receives FDA Clearance for Tensyn(TM) Band for AC/CC Joint Stabilization
Devices Orthopaedic FDA
 HSMN NewsFeed - 8 Oct 2014
EndoGastric Solutions Announces Publication of Study Demonstrating Benefits of TIF Procedure in Controlling GERD Symptoms
Devices Gastroenterology
 HSMN NewsFeed - 6 Oct 2014
Mylan Launches Generic Combivir
Biopharmaceuticals Generics HIV/AIDS Product Launch
 HSMN NewsFeed - 1 Oct 2014
Cardio3 Biosciences Announces New Business Development Strategy To Broaden Its Product Pipeline
Regenerative Medicine
 HSMN NewsFeed - 26 Sep 2014
Sumitomo Dainippon Pharma and SanBio Conclude Joint Development and License Agreement for North America over SB623, Therapy for Stroke
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 19 Sep 2014
European Commission Grants Marketing Authorization for Gilead’s Zydelig(R) (Idelalisib) for the Treatment of Chronic Lymphocytic Leukemia and Follicular Lymphoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 Sep 2014
Tryton Medical Completes $20 Million Equity Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 27 Aug 2014
Ligand Partner GlaxoSmithKline Receives U.S. FDA Approval for Promacta(R)/Revolade(TM) For Use in Patients with Severe Aplastic Anemia
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Aug 2014
Aldea Pharmaceuticals Closes $24 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Aug 2014
FDA Approves Use of AFLURIA(R) Influenza Vaccine with PharmaJet’s Needle-Free Injector
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 30 Jul 2014
Celldex Therapeutics Announces Senior Leadership Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jul 2014
Teleflex Receives FDA Clearance for 150 cm Length Arrow(R) GPSCath(R) Balloon Dilatation Catheters
Devices Interventional FDA
 HSMN NewsFeed - 25 Jul 2014
European Medicines Agency (EMA) Issues Positive Opinion, Recommends Full Approval of IMBRUVICA(R) (ibrutinib) for Treatment of Two Blood Cancers
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 Jul 2014
Boston Scientific Receives CE Mark For Agent(TM) Drug-Coated Balloon
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 22 Jul 2014
Teleflex Receives FDA Clearance for ARROW-Clark(TM) VectorFlow(TM) Chronic Hemodialysis Catheter
Devices FDA
 HSMN NewsFeed - 1 Jul 2014
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jun 2014
Cidara Therapeutics Completes $32 Million Series A Financing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2014
New Philips NeuroSuite Reveals the Brain's Vascular Network like Never Before
Devices Neurology Interventional Radiology
 HSMN NewsFeed - 12 Jun 2014
Cardiovascular Systems Announces Plans for New Corporate Headquarters
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Jun 2014
GSK and Theravance Announce Positive Data From Two Studies Evaluating the Efficacy and Safety of Incruse(TM) Ellipta(R) When Added to Relvar(R)/Breo(R) Ellipta(R) in Patients With COPD
Biopharmaceuticals
 HSMN NewsFeed - 10 Jun 2014
Avanir Pharmaceuticals Announces Positive Outcome of Phase IIIb COMPASS Trial: A Head-to-Head Study Comparing AVP-825 to Oral Sumatriptan for the Acute Treatment of Migraine
Biopharmaceuticals
 HSMN NewsFeed - 5 Jun 2014
QT Vascular Announces FDA Clearance of Chocolate PTCA Balloon Catheter
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 22 May 2014
Covidien Releases Two-Year Study Results Demonstrating Sustained Effectiveness of Drug-Coated Angioplasty Balloon Technology
Devices Interventional
 HSMN NewsFeed - 12 May 2014
FDA Approves ZONTIVITY(TM) (vorapaxar), First-in-Class PAR-1 Antagonist, for the Reduction of Thrombotic Cardiovascular Events in Patients with a History of Heart Attack or with Peripheral Arterial Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 1 May 2014
Boston Scientific Launches Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System In Japan
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Apr 2014
Novartis gains FDA approval for Zykadia(TM), first therapy for patients with ALK+ NSCLC previously treated with the ALK inhibitor crizotinib
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Apr 2014
Actinium Announces Key Additions to Senior Management Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Apr 2014
Chimerix Announces Appointment of M. Michelle Berrey, M.D., M.P.H. as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Apr 2014
CardioDx and Medison Israel Enter Into an Exclusive Corus(R) CAD Product Marketing and Sales Agreement
Diagnostics Cardiology Distribution
 HSMN NewsFeed - 8 Apr 2014
CardiAQ(TM) Valve Technologies Inc. (CardiAQ) appoints Paul Cornelison as Vice President of Regulatory Affairs, Quality Assurance & Clinical Affairs
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 3 Apr 2014
Holaira Closes $42 Million Venture Financing Round
Devices Venture Capital Personnel
 HSMN NewsFeed - 3 Apr 2014
Astellas Announces European Regulatory Submission For XTANDI(R) (enzalutamide) Capsules For Chemotherapy-Naive Metastatic Prostate Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 1 Apr 2014
Chimerix Appoints Lisa Ricciardi to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2014
Cesca Therapeutics Submits pre-IDE Information Package to FDA for Surgwerks(TM) CLI therapy System
Regenerative Medicine FDA
 HSMN NewsFeed - 26 Mar 2014
FDA Approves Optiguide(R) DCYL700 Fiber Optic Diffuser Series Flexible Fiber
Devices FDA
 HSMN NewsFeed - 25 Mar 2014
BrainStorm and Massachusetts General Hospital Sign Definitive Agreement for ALS Clinical Trial
Regenerative Medicine Neurology
 HSMN NewsFeed - 18 Mar 2014
NeoGenomics Announces Next Generation Sequencing Tests for Solid Tumor Cancers and Myelodysplastic Syndrome
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 17 Mar 2014
Hokkaido University and Hitachi Complete a Facility Incorporating a Novel Proton Beam Therapy System for Cancer Treatment Developed Jointly under Japan's FIRST Program
Devices Oncology
 HSMN NewsFeed - 14 Mar 2014
GSK and Theravance Announce Positive Results From Studies Comparing ANORO(TM) ELLIPTA(TM) With SERETIDE(R) DISKUS(R) and ADVAIR(R) DISKUS(R) in Patients With COPD
Biopharmaceuticals
 HSMN NewsFeed - 12 Mar 2014
Rosetta Genomics Provides Product Pipeline Update
Diagnostics
 HSMN NewsFeed - 4 Mar 2014
SharedClarity Awards First Contracts
Devices Interventional Cardiology Group Purchasing
 HSMN NewsFeed - 19 Feb 2014
Parametric Sound Receives FDA Clearance for HyperSound
Devices FDA
 HSMN NewsFeed - 19 Feb 2014
Smith & Nephew introduces the POLARSTEM(TM) cementless hip stem to the US market
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 17 Feb 2014
New Study Affirms In-Office Multi-Sinus Balloon Dilation is an Effective, Well Tolerated Treatment Option for Chronic Sinusitis Sufferers
Devices
 HSMN NewsFeed - 13 Feb 2014
Medtronic Launches 'TOTAL Across' Crossing Catheter in Europe
Devices Interventional Product Launch
 HSMN NewsFeed - 7 Feb 2014
Covis Pharmaceuticals Announces Its New Expanded Dosage Options of LANOXIN(R) for Cardiac Patients With Mild-to-Moderate Heart Failure
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 20 Jan 2014
Aegerion Pharmaceuticals' JUXTAPID(R) (lomitapide) Capsules Approved in Mexico for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 15 Jan 2014
Antares Pharma Announces Availability of OTREXUP (Methotrexate) Injection for Subcutaneous Use to Treat Rheumatoid Arthritis (RA) and Psoriasis in Adults, and Polyarticular Idiopathic Arthritis (pJIA) in Children
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 14 Jan 2014
ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme(TM) Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Jan 2014
Galena Biopharma Acquires Mills Pharmaceuticals, LLC
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Jan 2014
Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
Biopharmaceuticals
 HSMN NewsFeed - 7 Jan 2014
Dr. Seth Rudnick Joins G1 Therapeutics as Executive Chairman
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Jan 2014
Cell Therapeutics Announces Removal of the Partial Clinical Hold on Tosedostat
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Dec 2013
Tryton Medical Establishes Bifurcation Institute
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Dec 2013
Chimerix Appoints Linda M. Richardson as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Dec 2013
America Stem Cell, Inc. Changes Its Name to Targazyme, Inc.
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 13 Dec 2013
Neumedicines Presents HemaMax(TM) Clinical Data at the ASH Conference
Biopharmaceuticals
 HSMN NewsFeed - 12 Dec 2013
St. Jude Medical Gains CE Mark for 25 mm Portico Transcatheter Aortic Heart Valve
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 11 Dec 2013
FDA Grants Priority Review for Genzyme’s Cerdelga(TM) (eliglustat), an Investigational Oral Therapy for Gaucher Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Dec 2013
Boston Scientific and The Medicines Company Announce U.S. Co-Promotion Agreement for Promus PREMIER(TM) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Dec 2013
Physicians Throughout U.S. Using Cardiovascular Systems’ New Technology to Treat Coronary Artery Disease
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 2 Dec 2013
Siemens Launches Artis one Angiography System for Universal Use
Devices Radiology Product Launch
 HSMN NewsFeed - 22 Nov 2013
Threshold Pharmaceuticals Announces New Clinical Data on TH-302 and Avastin(R) (Bevacizumab) in Recurrent Glioblastoma Following Bevacizumab Failure
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Nov 2013
Actinium Pharmaceuticals Announces Plans For Iomab(TM)-B Phase 3 Pivotal Trial Following Meeting With FDA
Biopharmaceuticals
 HSMN NewsFeed - 15 Nov 2013
Boston Scientific Announces First Commercial Implants Of The Lotus(TM) Valve System in Europe
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 30 Oct 2013
REVA Announces Transmission of ReZolve2 Implant and Pilot Trial Update at TCT 2013
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Oct 2013
Pharmalink Receives US Orphan Drug Designation for Busulipo(TM), its Novel Oncology Product for Bone Marrow Transplantation
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Oct 2013
Boston Scientific Receives CE Mark For Lotus(TM) Valve System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 22 Oct 2013
Cardiovascular Systems, Inc. Receives Coronary FDA Approval
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 18 Oct 2013
ARIAD Announces Discontinuation of the Phase 3 Epic Trial of Iclusig in Patients with Newly Diagnosed Chronic Myeloid Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Oct 2013
G1 Therapeutics Raises $12.5M Series A Financing Led by MedImmune Ventures
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 14 Oct 2013
Teleflex Releases White Paper on Reducing PICC-Related Infection and Thrombosis
Devices
 HSMN NewsFeed - 3 Oct 2013
Aubagio(R) Significantly Reduced Risk of New Clinical Relapse or MRI Lesion in Multiple Sclerosis Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Oct 2013
Cook Medical Marks One-Year Anniversary of its Otolaryngology/Head and Neck Surgery Division
Devices Otolaryngology
 HSMN NewsFeed - 1 Oct 2013
Russ Trenary to Lead InnFocus, Inc.
Devices Ophthalmology Personnel
 HSMN NewsFeed - 30 Sep 2013
Entellus Medical & CogENT Therapeutics Announce Distribution Agreement
Devices Distribution
 HSMN NewsFeed - 26 Sep 2013
Lumena Pharmaceuticals Receives Orphan Drug Designation from US Food & Drug Administration for LUM001 in Four Rare Liver Diseases
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Sep 2013
FDA Approves Medtronic's Complete 'SE' Vascular Stent for Use in Superficial Femoral and Proximal Popliteal (Leg) Arteries
Devices Interventional FDA
 HSMN NewsFeed - 20 Sep 2013
RELVAR(TM) ELLIPTA(TM) Gains Approval in Japan for the Treatment of Asthma
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Sep 2013
Published Study Demonstrates Benefits of Balloon Sinus Dilation versus Endoscopic Sinus Surgery for Sinusitis Patients
Devices Interventional
 HSMN NewsFeed - 19 Sep 2013
Arrowhead Promotes David Lewis to Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Sep 2013
Teleflex Features ARROW(R) JACC with Chlorag+ard(R) Technology, the Only Long-Term Antimicrobial and Antithrombogenic CVC, and ARROW(R) VPS G4(TM) Vascular Positioning Device at the 2013 AVA Conference
Devices Product Launch
 HSMN NewsFeed - 17 Sep 2013
Abbott Receives CE Mark for FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System(TM)
Devices Diagnostics Monitoring Regulatory
 HSMN NewsFeed - 16 Sep 2013
FDA Grants Soligenix Orphan Drug Designation for SGX94 for Treatment of Acute Radiation Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Sep 2013
Actinium Pharmaceuticals Appoints Kaushik J. Dave, Ph.D., MBA As President, Chief Executive Officer And Director
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Sep 2013
Entellus Medical Launches Cordless Trans-illumination Product for Use with the XprESS LoProfile Balloon Multi-Sinus Dilation Device for the Treatment of Sinusitis
Devices Product Launch
 HSMN NewsFeed - 21 Aug 2013
Abbott Completes Acquisition of IDEV Technologies
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 12 Aug 2013
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Drug/Non-Drug Eluting Coronary Stents, Diagnostic and Interventional Cardiology Products
Devices Interventional Cardiology Group Purchasing
 HSMN NewsFeed - 8 Aug 2013
European Commission Approves VELCADE(R) as a Frontline Induction Therapy before Stem Cell Transplantation
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 25 Jul 2013
Study Shows Benefits of Balloon Sinus Dilation versus Traditional Sinus Surgery for Chronic Sinusitis
Devices
 HSMN NewsFeed - 23 Jul 2013
BIOLASE Names Medical Device Marketing Veteran Orlando Rodrigues as Vice President, Marketing
Devices Dental Personnel
 HSMN NewsFeed - 22 Jul 2013
MicroVention Announces First Trial Enrollment In Their U.S. Clinical Trial Of Its New Dual-Layer Stent For Cerebral Aneurysm Flow Diversion
Devices Interventional Neurology
 HSMN NewsFeed - 22 Jul 2013
SynGen Hires Former Pall Medical Executive as President of Cord Blood Business Unit
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 18 Jul 2013
Mother of Four with Congenital Heart Defect & Biventricular Heart Failure Bridged to Transplant with the SynCardia Total Artificial Heart
Devices Cardiology
 HSMN NewsFeed - 15 Jul 2013
Abbott to Acquire IDEV Technologies to Expand Global Peripheral Technology Portfolio
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 10 Jul 2013
STENTYS Self-Apposing Stent Approved in Europe for Additional Coronary Indications
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 2 Jul 2013
Sequenta Completes $20 Million Series C Financing
Diagnostics Oncology Venture Capital Personnel
 HSMN NewsFeed - 2 Jul 2013
ARIAD Announces Marketing Authorization for Iclusig(R) (ponatinib) in the European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 Jun 2013
XTANDI(TM) (Enzalutamide) Authorized in the European Union for Advanced Prostate Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 18 Jun 2013
Rockwell Medical Receives $20 Million in New Financing
Biopharmaceuticals
 HSMN NewsFeed - 10 Jun 2013
Teleflex Receives FDA Clearance for ARROW NextStep Retrograde Femoral Length Dialysis Catheters
Devices FDA
 HSMN NewsFeed - 5 Jun 2013
Astellas Signs Distribution Agreement With Tecnofarma For Enzalutamide In Latin America
Biopharmaceuticals Distribution
 HSMN NewsFeed - 3 Jun 2013
Teva’s Lonquex(R)(XM22 lipegfilgrastim) Recommended for Approval in the EU for the Reduction of Chemotherapy-Induced Neutropenia (CIN)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 31 May 2013
Oral Anti-Cancer Therapy Pomalidomide Celgene Receives Positive CHMP Opinion as Treatment for Patients with Relapsed and Refractory Multiple Myeloma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 29 May 2013
Teleflex Announces European Market Clearance for its Arrow(R) GPSCath(R) Balloon Dilatation Catheter
Devices Interventional Regulatory
 HSMN NewsFeed - 24 May 2013
Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 May 2013
Boston Scientific Promus PREMIER(TM) and SYNERGY(TM) Drug-Eluting Stent Systems Provide Exceptional Safety and Efficacy Data
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2013
Covidien Announces Clinical Trial Data Showing Endoscopic Ablation Therapy Eliminates Precancerous Esophageal Tissue and Significantly Reduces Disease Progression
Devices Gastroenterology
 HSMN NewsFeed - 21 May 2013
Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 16 May 2013
St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 6 May 2013
Arrowhead Closes $36 Million Private Offering
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Apr 2013
Teleflex Receives FDA 510(k) Clearance for Next Generation Vascular Positioning System(R)
Devices FDA
 HSMN NewsFeed - 23 Apr 2013
FDA Approves Second Drug in BD Simplist(TM) Prefilled Injectable Line of Products
Biopharmaceuticals Devices Drug Delivery Generics FDA
 HSMN NewsFeed - 15 Apr 2013
Teleflex Signs New Agreement with HealthTrust for Anesthesia Products
Devices Group Purchasing
 HSMN NewsFeed - 4 Apr 2013
First Patient Treated Worldwide with the new TomoEDGE(TM) Dynamic Jaws Technology
Devices Oncology
 HSMN NewsFeed - 3 Apr 2013
Collegium Pharmaceutical Names Douglas Carlson to Vice President of Business Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 27 Mar 2013
BD Enters Pharmaceutical Industry with New Line of Generic Prefilled Injectable Products
Biopharmaceuticals Generics Drug Delivery FDA
 HSMN NewsFeed - 26 Mar 2013
Acceleron Receives Two FDA Orphan Designations for ACE-536
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Mar 2013
Clinigen Group plc Acquires Oncology Support Therapy Cardioxane(R) from a World-Leading Pharmaceutical Company
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 25 Mar 2013
Angiotech announces sale of Interventional Products Business to Argon Medical Devices, Inc.
Devices Interventional Acquisitions
 HSMN NewsFeed - 18 Mar 2013
Cytomedix Announces Centers for Medicare & Medicaid Services (CMS) Issuance Of Reimbursement Coding for Autologous PRP in Chronic Non-Healing Wounds
Regenerative Medicine Wound Care Reimbursement
Return to NewsFeed  

 Additional items found! 500

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 500 additional stories matching:
Arrow
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.